Chemoimmunotherapy for the treatment of chronic lymphocytic leukemia (CLL) has been present for over a decade now. With the advent of newer targeted therapies having a better safety and efficacy profile, the treatment landscape in CLL is now evolving. In this regard, AstraZeneca Medical Team and Docplexus team have organized an interactive session on 31 st March 2021 at 7.00 PM. In this session, experts, Dr. Sameer A.
Tulpule , Dr. Vivek Radhakrishnan , and Dr. Sharat Damodar will discuss “Paradigm Shift in Treatment of Chronic Lymphocytic Leukemia-Novel Therapies Over Chemoimmunotherapy” . Agenda We invite you to submit your questions, which will be answered by the speakers at the end of the session.
